Evidence map›Paper›PMID 39478503›Full record

ArticleMolecular medicine (Cambridge, Mass.)2024

Endometriosis development in relation to hypoxia: a murine model study.

Marta Hoffmann-Młodzianowska, Radosław B Maksym, Katarzyna Pucia, Monika Kuciak, Andrzej Mackiewicz, Claudine Kieda

Abstract read
In one paragraph

Article in Molecular medicine (Cambridge, Mass.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Marta Hoffmann-MłodzianowskaLaboratory of Molecular Oncology and Innovative Therapies, Military Institute of Medicine - National Research Institute, 04-141, Warsaw, Poland. mhoffmann-mlodzianow@wim.mil.pl.
Radosław B Maksym1st Department of Obstetrics and Gynaecology, Centre of Postgraduate Medical Education, 01-004, Warsaw, Poland.
Katarzyna PuciaAnimal Experimentation Laboratory of the Center for Biostructure Research, Medical University of Warsaw, 02-106, Warsaw, Poland.
Monika KuciakChair of Medical Biotechnology, Poznan University of Medical Sciences, 61-806, Poznan, Poland.
Andrzej MackiewiczChair of Medical Biotechnology, Poznan University of Medical Sciences, 61-806, Poznan, Poland.
Claudine KiedaLaboratory of Molecular Oncology and Innovative Therapies, Military Institute of Medicine - National Research Institute, 04-141, Warsaw, Poland.

Funding

National Science Centre (NCN), Poland 2019/35/B/NZ6/04395
6 · The paper itself

Abstract

backgroundEndometriosis, due to its ambiguous symptoms, still remains one of the most difficult female diseases to treat, with an average diagnosis time of 7-9 years. The changing level of hypoxia plays an important role in a healthy endometrium during menstruation and an elevated expression of the hypoxia-inducible factor 1-alpha (HIF-1α) has been demonstrated in ectopic endometria. HIF-1α mediates the induction of proangiogenic factors and the development of angiogenesis is a critical step in the establishment and pathogenesis of endometriosis. Although the inhibition of angiogenesis has been proposed as one of the actionable therapeutic modalities, vascular normalization and re-oxygenation may become a possible new approach for therapeutic intervention.

methodsOur goal was to investigate whether a selected murine model of endometriosis would be suitable for future studies on new methods for treating endometriosis. Non-invasive, high-resolution ultrasound-monitored observation was selected as the preclinical approach to obtain imaging of the presence and volume of the endometriotic-like lesions. The EF5 (2-(2-Nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)acetamide) compound that selectively binds to reduced proteins in hypoxic cells was used for hypoxia detection. The expression of Pten and other crucial genes linking endometriosis and hypoxia were also assessed.

resultsUsing EF5, a pentafluorinated derivative of the 2-nitroimidazole that is metabolically reduced by oxygen-inhibitable nitroreductase, we confirmed that hypoxia did develop in the selected model and was detected in uterine and ectopic endometriotic lesions. Moreover, the changes in oxygen tension also influenced the expression level of significant genes related to endometriosis, like Pten, Trp53, Hif1a, Epas1, and Vegfa. Their strong modulation evidenced here is indicative of model reliability. Using high-resolution ultrasound-based imaging, we present a non-invasive method of visualization that enables the detection and observation of lesion evolution throughout the duration of the experiment, which is fundamental for further preclinical studies and treatment evaluation.

conclusionsThe selected model and method of visualization appear to be suitable for the study of new treatment strategies based on hypoxia alleviation and blood flow restoration.

Indexed as

Disease Models, AnimalEndometriosisHypoxia-Inducible Factor 1, alpha SubunitAnimalsEndometriumFemaleHumansHypoxiaMiceNeovascularization, PathologicPTEN PhosphohydrolaseHypoxia-Inducible Factor 1, alpha SubunitPTEN PhosphohydrolaseEF5EndometriosisHigh-resolution ultrasoundHypoxiaMurine model of endometriosisPTEN

Identifiers

PMID39478503
PMCPMC11526686

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.